Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201

NCT02075008 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
270
Enrollment
INDUSTRY
Sponsor class

Stopped The study was prematurely terminated after core study CQGE031B2201 failed to meet the primary objective of demonstrating superiority for QGE031 versus placebo.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals